Suberoylanilide hydroxamic acid sensitizes neuroblastoma to paclitaxel by inhibiting thioredoxin‐related protein 14‐mediated autophagy

作者: Zijun Zhen , Kaibin Yang , Litong Ye , Zhiyao You , Rirong Chen

DOI: 10.1111/CAS.13279

关键词:

摘要: Paclitaxel is not as effective for neuroblastoma most of the front-line chemotherapeutics due to drug resistance. This study explored regulatory mechanism paclitaxel-associated autophagy and potential solutions paclitaxel resistance in neuroblastoma. The formation autophagic vesicles was detected by scanning transmission electron microscopy flow cytometry. autophagy-associated proteins were assessed western blot. Autophagy induced LC3-I, LC3-II, Beclin 1, thioredoxin-related protein 14 (TRP14), found be up-regulated cells that exposed paclitaxel. inhibition 1 or TRP14 siRNA increased sensitivity tumor In addition, 1-mediated regulated TRP14. Furthermore, inhibitor suberoylanilide hydroxamic acid (SAHA) down-regulated paclitaxel-induced enhanced anticancer effects normal control cancer but with expression. Our findings showed SAHA could sensitize specifically inhibiting TRP14. This article protected copyright. All rights reserved.

参考文章(42)
Solmaz Khaghani-Razi-Abad, Mehrdad Hashemi, Mehdi Pooladi, Maliheh Entezari, Elham Kazemi, Proteomics analysis of human oligodendroglioma proteome Gene. ,vol. 569, pp. 77- 82 ,(2015) , 10.1016/J.GENE.2015.05.039
So Young Yoo, Jung-Sun Kim, Ki Woong Sung, Tae Yeon Jeon, Joon Young Choi, Seung Hwan Moon, Meong Hi Son, Soo Hyun Lee, Keon Hee Yoo, Hong Hoe Koo, The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high‐risk neuroblastoma Cancer. ,vol. 119, pp. 656- 664 ,(2013) , 10.1002/CNCR.27775
Jesús García-Cano, Gorbatchev Ambroise, Raquel Pascual-Serra, Maria Carmen Carrión, Leticia Serrano-Oviedo, Marta Ortega-Muelas, Francisco J. Cimas, Sebastià Sabater, María José Ruiz-Hidalgo, Isabel Sanchez Perez, Antonio Mas, Félix A. Jalón, Aimé Vazquez, Ricardo Sánchez-Prieto, Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance Oncotarget. ,vol. 6, pp. 15551- 15565 ,(2015) , 10.18632/ONCOTARGET.3902
Irene Riz, Teresa S Hawley, Robert G Hawley, None, KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models Oncotarget. ,vol. 6, pp. 14814- 14831 ,(2015) , 10.18632/ONCOTARGET.4530
Joo Rang Woo, Seung Jun Kim, Woojin Jeong, Yoon Hea Cho, Sang Chul Lee, Yong Je Chung, Sue Goo Rhee, Seong Eon Ryu, Structural basis of cellular redox regulation by human TRP14 Journal of Biological Chemistry. ,vol. 279, pp. 48120- 48125 ,(2004) , 10.1074/JBC.M407079200
FEIFEI LIU, DONGLEI LIU, YANG YANG, SONG ZHAO, Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells. Oncology Letters. ,vol. 5, pp. 1261- 1265 ,(2013) , 10.3892/OL.2013.1154
Giselle L. Saulnier Sholler, Jeffrey P. Bond, Genevieve Bergendahl, Akshita Dutta, Julie Dragon, Kathleen Neville, William Ferguson, William Roberts, Don Eslin, Jacqueline Kraveka, Joel Kaplan, Deanna Mitchell, Nehal Parikh, Melinda Merchant, Takamaru Ashikaga, Gina Hanna, Pamela Jean Lescault, Ashley Siniard, Jason Corneveaux, Matthew Huentelman, Jeffrey Trent, Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma Cancer Medicine. ,vol. 4, pp. 871- 886 ,(2015) , 10.1002/CAM4.436
Norihiko Furuya, Jie Yu, Maya Byfield, Sophie Pattingre, Beth Levine, The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy. ,vol. 1, pp. 46- 52 ,(2005) , 10.4161/AUTO.1.1.1542
R A Veldhoen, S L Banman, D R Hemmerling, R Odsen, T Simmen, A J Simmonds, D A Underhill, I S Goping, The Chemotherapeutic Agent Paclitaxel Inhibits Autophagy Through Two Distinct Mechanisms That Regulate Apoptosis Oncogene. ,vol. 32, pp. 736- 746 ,(2013) , 10.1038/ONC.2012.92